Myeloproliferative neoplasms (MPN) are cancers that start in the bone marrow, where blood cells are made.
In MPN, the bone marrow makes too many of one or more types of blood cells (red blood cells, white blood cells and/or platelets). These cells change the thickness of the blood. Sometimes they don’t work properly. They also crowd the bone marrow and then it can’t make enough healthy blood cells.
A disease-specific Optimal Care Pathway has been developed for myeloproliferative neoplasms (MPN), accompanied by a quick reference guide and patient guide, specially designed to help people in Australia with blood cancer, and their loved ones. The OCP patient guides are suitable to be shared with your patients, to ensure they are informed of their upcoming blood cancer journey.
Myeloproliferative neoplasms (MPN)
Comprehensive Optimal Care Pathway for myeloproliferative neoplasms (MPN)
A comprehensive pathway to encourage consistent optimal treatment and supportive care at each stage of a patient’s journey
Quick reference guide for the OCP for myeloproliferative neoplasms (MPN)
A quick reference guide to encourage consistent optimal treatment and supportive care at each stage of a patient’s journey
Guide to best cancer care for myeloproliferative neoplasms (MPN)
A sipmlified guide that is suitable for sharing with your patient
Optimal Care Pathways are one of the key recommendations in Australia’s National Strategic Action Plan for Blood Cancer. They will help you, as a health professional, provide nationally consistent, high-quality, evidence-based information at each stage of the blood cancer pathway, from diagnosis and treatment to ongoing care.
